Director, Scientific Strategy
Merz Therapeutics
Mike Hast, PhD, is the Director of Scientific Strategy for Merz Therapeutics Medical Affairs. He leads the development of educational initiatives around botulinum toxin injection and has a special interest in late stage research programs such as real world evidence generation. Mike holds a PhD in biochemistry from Duke University and a BS in biochemistry from North Carolina State University.